Katherine Green - February 2, 2024 Most opposed patents of 2023 Multiple sclerosis therapies are the subject of two of the most opposed patents of 2023. Novartis’ ...
Katherine Green - November 13, 2023 Most opposed patents of 2022 As with CRISPR, patents directed to Nobel Prize-winning technologies are viewed as extremely ...
Katherine Green - November 7, 2022 Eight days – the longest ever opposition hearing at the EPO? The EPO Opposition Division just issued its decision on European Patent 2 188 302 following an ...
Katherine Green - July 28, 2022 Most opposed patents of 2021 When we reviewed our list of the most opposed European patents of 2021, we found that the patent at ...
Katherine Green - January 26, 2022 A guide to EPO opposition proceedings by videoconference EPO oppositions by videoconference only became possible relatively recently, in April 2020. In 2021 ...
Jacqueline Murphy - September 30, 2021 Mewburn Ellis: top tier firm Legal 500 2022 Mewburn Ellis is proud to be ranked top tier for our patent and trade mark practices in the 2022 ...
Katherine Green - September 6, 2021 Most opposed patents of 2020 Every year at the EPO about 3000-4000 patents are opposed. This figure represents only about 3-4% ...
Katherine Green - October 9, 2020 Nobel Prize in Chemistry awarded for CRISPR "genetic scissors" In 2012, Jennifer Doudna and Emmanuelle Charpentier published their ground-breaking paper in ...
Jacqueline Murphy - October 1, 2020 Mewburn Ellis: top tier firm Legal 500 2021 We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...
Katherine Green - August 21, 2020 Most Opposed Patents of 2019 The four thousand or so European patents that are opposed every year represent only about 3% of all ...
Katherine Green - February 24, 2020 EPO streamlining: the opposition timeline tightens Our analysis of patent oppositions has revealed that early action has become imperative for ...
Katherine Green - November 14, 2019 EPO oppositions: Nine key questions answered Mewburn Ellis has dug deep into a decade of EPO life sciences' decisions to discover fresh insights ...
Katherine Green - November 5, 2019 Meet The Team: Katherine Green, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Katherine Green about her journey to becoming a ...
Katherine Green - October 30, 2019 Oppositions - a case to remember. Flexibility around added matter Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)